SAB Biotherapeutics SABS
NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

SAB Biotherapeutics (SABS) Change in Receivables (2021 - 2023)

Updated

SAB Biotherapeutics' Change in Receivables came in at -$5.56 million for FY2023, compared with -$2.45 million in FY2022.

Analysis

SAB Biotherapeutics (SABS) Change in Receivables (2021 - 2023) Analysis & Trends

Going back to FY2020, SAB Biotherapeutics' Change in Receivables data covers 4 years.

  • The five-year range for annual Change in Receivables is -$12.56 million (FY2021) to $17.75 million (FY2020).
  • Per Business Quant, earlier years put Change in Receivables at -$2.45 million in FY2022, -$12.56 million in FY2021 and $17.75 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 SAB Biotherapeutics 279.79 Mn -130.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -361,735.00
Jun 30, 2023 -401,388.00
Mar 31, 2023 -4.79 Mn
Dec 31, 2022 -7.39 Mn
Sep 30, 2022 3.33 Mn
Jun 30, 2022 -2.17 Mn
Mar 31, 2022 3.78 Mn
Dec 31, 2021 -2.20 Mn
Sep 30, 2021 -6.90 Mn
Jun 30, 2021 5.52 Mn
Mar 31, 2021 -8.98 Mn
API Access

SAB Biotherapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SABS&period=max&api_key=YOUR_API_KEY